• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What are Clinical Trials?
    • Become a Clinical Trial Volunteer
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Illumina hires Garret Hampton to head Clinical Genomics Unit

Illumina hires Garret Hampton to head Clinical Genomics Unit

January 3, 2017
CenterWatch Staff

Illumina, continuing its strategy to bring the power of genomics into clinical applications, has named one of the world’s top clinical genomics experts to head its clinical genomics unit. Garret Hampton, Ph.D., will join as executive vice president of Clinical Genomics for the company, starting January 9, 2017.

“This is a strategically important hire for Illumina,” said Francis deSouza, president and chief executive officer of Illumina. “Garret has been on the front lines of oncology and brings deep expertise in clinical genomics to the leadership team, key to his new role leading our clinical genomics organization.”

Garret will be responsible for leading the clinical genomics group, including the reproductive and genetic health and oncology businesses, regulatory, clinical and medical affairs, CLIA labs and the chief medical officer’s organization. He joins Illumina from Genentech, where he was global head of Oncology Biomarker Development and Companion Diagnostics, co-led the Roche Personalized Medicine R&D Initiative and chaired the Roche/Foundation Medicine Joint R&D Committee. He previously held scientific and management roles at Celgene, Genomics Institute of the Novartis Research Foundation and University of California at San Diego. Garret holds a BA in natural sciences and genetics and MA in natural sciences from Trinity College in Dublin, Ireland, and a Ph.D. in cancer genetics from Imperial Cancer Research Fund and the University College London.

    Upcoming Events

    • 05Dec

      Thriving in Clinical Research – Overcoming Common Challenges as a Site: Part 3 – Site Resourcing

    • 14Apr

      MAGI 2024: The Clinical Research Conference

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Jonathan Seltzer

      Thought Leadership: Remote Patient Monitoring Gives New View of Safety in Cardiac Clinical Trials

    • Quality_Compass-360x240.png

      Ask the Experts: Applying Quality by Design to Protocols

    • Obesity Treatment Patient

      Clinical Trials Need Greater Representation of Obese Patients, Experts Say

    • Modernize-360x240.png

      FDA IT Modernization Plan Prioritizes Data-Sharing, AI, Collaboration and More

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing